View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML

DOJ/DEA RIN: 1117-AB06 Publication ID: Fall 2008 
Title: Implementation of the Combat Methamphetamine Epidemic Act of 2005; Notice of Transfers Following Importation or Exportation 
Abstract: This rule implements the "spot market" [provisions] of the Combat Methamphetamine Epidemic Act of 2005 (title VII of Pub. L. 109-177). Importers, exporters, and persons conducting international transactions of all List I and List II chemicals will now be required to provide DEA with information on the person to whom they will transfer the listed chemicals and the amount to be transferred, and must now provide a return declaration once the importation, exportation, or international transaction has occurred. These provisions will allow DEA to monitor efficiently the flow of chemicals that can be used illicitly to manufacture controlled substances. 
Agency: Department of Justice(DOJ)  Priority: Other Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Final Rule Stage 
Major: No  Unfunded Mandates: No 
CFR Citation: 21 CFR 1300    21 CFR 1313   
Legal Authority: 21 USC 802    21 USC 830    21 USC 871(b)    21 USC 951    21 USC 958(f)    21 USC 971   
Legal Deadline:  None
Timetable:
Action Date FR Cite
Interim Final Rule with Request for Comments  04/09/2007  72 FR 17401   
Interim Final Rule Effective  05/09/2007    
Interim Final Rule Comment Period End  05/09/2007    
Temporary Stay of Certain Provisions  05/22/2007  72 FR 28601   
Final Action  05/00/2009    
Additional Information: Docket DEA-292
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: No  Federalism: No 
Included in the Regulatory Plan: No 
RIN Information URL: www.regulations.gov  
RIN Data Printed in the FR: No 
Agency Contact:
Mark W. Caverly
Chief, Liaison and Policy Section
Department of Justice
Drug Enforcement Administration
8701 Morrissette Drive,
Springfield, VA 22152
Phone:202 307-7297
Email: dea.diversion.policy@usdoj.gov